BioXcel Therapeutics NEW HAVEN, Conn., July 30, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company leveraging artificial intelligence to develop transformative medicines...
Spero Therapeutics, Inc. CAMBRIDGE, Mass., July 29, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), LOS ANGELES, Aug. 15, 2024 (GLOBE NEWSWIRE) — Biopharmaceuticals, Inc.,...
Altimune, Inc. GAITHERSBURG, Md., June 26, 2024 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Richard Eisenstadt, the company’s chief...
